Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1993
06/16/1993EP0546583A1 Piperazinyl-and piperidinyl-cyclohexanols
06/16/1993EP0546475A1 Biologically active pseurotin A and D, new metabolites from Aspergillus fumigatus, process for their preparation and their use as apomorphine antagonists
06/16/1993EP0546474A1 Pseurotin F1/F2, new metabolites from Aspergillus fumigatus, process for their preparation and their use as apomorphine antagonists
06/16/1993EP0546389A1 Piperidylmethyl substituted chroman derivatives as agents for the treatment of diseases of the central nervous system
06/16/1993EP0546388A1 Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
06/16/1993EP0546164A1 Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
06/16/1993EP0546160A1 Method of reversing local anesthesia and reagent system therefor
06/16/1993EP0546123A1 Alpha-substituted tryptophane dipeptoid derivatives
06/16/1993EP0546108A1 Pro-drugs for cck antagonists
06/16/1993EP0546102A1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases.
06/16/1993EP0546101A1 METHOD OF INTERFERING WITH FORMATION OF $g(a)-ANTICHYMOTRYPSIN-$g(b)-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN
06/16/1993EP0546084A1 PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID $g(b)-PROTEIN PRECURSOR
06/16/1993EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
06/16/1993EP0546005A1 1,2,5,6-tetrahydropyridine oxime derivatives
06/16/1993CN1073174A Heterocyclic derivatives
06/16/1993CN1073095A Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
06/15/1993US5220017 Gastrointestinal, central nervous system disorders
06/15/1993US5219872 Treating Alzheimer*s disease, memory disorders
06/15/1993US5219871 Muscarinic receptor antagonists
06/15/1993US5219860 Spirocyclic antipsychotic agents
06/15/1993CA1319151C2 ¬¬(3-pyridinyl)methylene|amino|alcohols
06/15/1993CA1319109C Spray dried ibuprofen
06/14/1993WO1993012119A1 Thiadiazine carboxylic acid amide derivatives, methods of preparing them and drugs containing them
06/14/1993CA2103891A1 Thiadiazinecarboxamide derivatives, processes for their preparation and pharmaceuticals
06/10/1993WO1993011280A1 Multiple solvent cleaning system
06/10/1993WO1993011231A1 Tools for the diagnosis and treatment of alzheimer's disease
06/10/1993WO1993011122A1 Piperazine derivatives as 5-ht1a antagonists
06/10/1993WO1993011116A1 Novel azepine derivative, production thereof, and use thereof
06/10/1993WO1993011115A2 Quinolone derivatives and their use as nmda and ampa receptor antagonists
06/10/1993WO1993011110A1 Preparation of substituted piperidines
06/10/1993WO1993011107A1 Novel n-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives
06/10/1993WO1993011106A1 Indole derivatives
06/10/1993WO1993010806A1 Medicament for promoting growth of mammalian nerve
06/10/1993WO1993010783A2 Quinolone derivatives and their use as ampa and nmda receptor antagonists
06/10/1993WO1993010781A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
06/10/1993WO1993010779A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
06/10/1993WO1993010742A2 Chemical compounds, their preparation and use
06/10/1993CA2125298A1 Tools for the diagnosis and treatment of alzheimer's disease
06/10/1993CA2125149A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
06/10/1993CA2124445A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
06/10/1993CA2123216A1 Novel n-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives
06/10/1993CA2123207A1 Multiple solvent cleaning system
06/10/1993CA2122841A1 Quinolone derivatives
06/10/1993CA2122840A1 Quinolone derivatives
06/10/1993CA2084542A1 Novel azaheterocyclylmethyl-chromans
06/10/1993CA2084541A1 Piperidylmethyl-substituted chroman derivatives
06/09/1993EP0545845A1 Imidazole compounds, their preparation and use as calcium channel blockers
06/09/1993EP0545478A1 Heterocyclic compounds as tachykinin antagonists
06/09/1993EP0545425A1 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments
06/09/1993EP0545421A1 4-(4-piperidinyl-thieno(3,2-c)pyridine derivatives of N-alkylglutarimides as antipsychotic agents
06/09/1993EP0545413A1 Novel trans cyclopentanyl purine analogs useful as immunosuppressants
06/09/1993EP0545120A2 Combination of 5-HT2-receptor antagonists and 5-HT1A-receptor agonists with neuroprotective effect
06/09/1993EP0545095A1 1,3-Substituted cycloalkenes and cycloalkanes as central nervous system agents
06/09/1993EP0544880A1 Method of preparing diacetyl rhein.
06/09/1993EP0544779A1 Heterocyclic compounds and their preparation and use
06/09/1993EP0544773A1 Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
06/09/1993EP0544756A1 1,2,5,6-tetrahydro-1-methylpyridines, their preparation and use
06/09/1993CN1072929A Para-dinitrogen naphthalene derivative its preparation process and its medical use
06/09/1993CN1072927A Novel N-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyriding and piperidine derivatives
06/09/1993CN1072843A Gel-type cosmetic composite
06/08/1993US5218115 Cholecystokinin antagonists
06/08/1993US5218114 Cholecystokinin antagonists
06/08/1993US5218000 Therapeutic polyamine-amides
06/08/1993US5217976 Hypotensive agents, congestive heart failure
06/08/1993US5217975 Azabicyclic compounds for treating dementia
06/08/1993US5217967 Agent with an antidepressant activity
06/07/1993CA2084568A1 Medicaments for treating inflammatory conditions or analgesia
06/06/1993CA2084365A1 4-(4-piperidinyl-thieno[3,2-c] pyridine derivatives of n-alkylglutarimides
06/04/1993CA2084233A1 Imidazole compounds, their preparation and use
06/04/1993CA2083891A1 Heterocyclic compounds, compositions containing them and their use in therapy
06/02/1993EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP)
06/02/1993EP0544475A1 Process for the synthesis of 3-phenoxy-1-azetidinecarboxamides
06/02/1993EP0544445A2 Furyl-substituted purines, oxazolopyrimidines and pteridines as adenosine antagonists
06/02/1993EP0544444A1 Processes for the preparation f substituted triazolo 1,5-a 1,3,5 triazines
06/02/1993EP0544443A1 Azole derivatives as adenosine antagonists
06/02/1993EP0544293A2 Process for the preparation of biologically active NGF by genetic engineering
06/02/1993EP0544240A1 Benzoquinoxalines and pharmaceutical compositions containing them
06/02/1993EP0543968A1 3-ARYL OR 3-HETERO-ARYL-$g(b)-CARBOLINES, THEIR PREPARATION AND THEIR USE IN DRUGS
06/02/1993CN1072679A 吲哚衍生物 Indole derivatives
06/01/1993US5216159 Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands
06/01/1993US5216018 Hydroisoindolines and hydroisoquinolines as psychotropic
06/01/1993US5216001 Central nervous system disorders
06/01/1993US5215964 Treating aging, depression, anxiety, autoimmune diseases
06/01/1993CA1318682C Disubstituted benzylamines, their preparation process, their use medicine and their synthesising agents
06/01/1993CA1318675C Substituted 9-amino-tetrahydroacridines and related compounds, a process for their preparation and their use as medicaments
06/01/1993CA1318669C Benzodiazepine compounds and their use as pharmaceuticals
06/01/1993CA1318602C Controlled release combination of carbidopa/levodopa
06/01/1993CA1318600C Sustained release etodolac
06/01/1993CA1318595C 2-alkoxy-n-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides
06/01/1993CA1318594C Beta blockers for the treatment of the progression of axial myopia in children
05/1993
05/29/1993CA2083914A1 Benzoquinoxalines
05/28/1993WO1993010765A1 Controlled release oxycodone compositions
05/27/1993WO1993010459A1 A method for assaying and treating alzheimer's disease
05/27/1993WO1993010233A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor
05/27/1993WO1993010092A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
05/27/1993WO1993010089A1 Novel amide compounds and medicinal use thereof
05/27/1993WO1993010075A1 N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists
05/27/1993WO1993010073A1 Acyclic ethylenediamine derivatives as substance p receptor antagonists
05/27/1993WO1993009802A2 Tgf-beta to improve neural outcome
05/27/1993WO1993009781A1 Sustained-release trapidil tablet
1 ... 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 ... 1833